Allecra Therapeutics, a clinical stage biopharmaceutical company, was established in 2013 and is dedicated to the development of novel treatments to combat multi drug-resistant bacterial infections. Allecra has a novel β-lactamase inhibitor in Phase 2 clinical development. By inhibiting β-lactamases Allecra’s new medicine directly tackles emerging resistance mechanisms of certain hard-to-treat bacteria. The product candidate has completed a pivotal phase III trial in cUTI showing superiority over standard of care
Location: France, Grand Est, Saint-Louis
Total raised: $44.35M
Investors 2
| Date | Name | Website |
| - | Forbion | forbion.co... |
| - | Andera Par... | anderapart... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.06.2016 | Series B | $24.78M | - |
| 18.04.2013 | Series A | $19.57M | Forbion |
Mentions in press and media 11
| Date | Title | Description | Source |
| 10.03.2024 | Blockbuster BeiGene Cancer Drug Adds Another FDA Approval | A BeiGene drug already used to treat several types of blood cancer now has an additional FDA approva... | medcitynew... |
| 27.02.2024 | Allecra Therapeutics Announces U.S. FDA Approval for EXBLIFE... | --Company Receives Five-year Exclusivity Extension Through GAIN Act -- SAINT-LOUIS, France & WEI... | forbion.co... |
| 21.12.2020 | Allecra Therapeutics and Shanghai Haini Pharmaceutical Annou... | Allecra, subject to the satisfaction of terms and conditions as set forth in the Exclusive Licensing... | marketscre... |
| 21.12.2020 | Allecra Therapeutics GmbH : and Shanghai Haini Pharmaceutica... | DGAP-News: Allecra Therapeutics GmbH / Key word(s): Agreement Allecra Therapeutics and Shanghai Hain... | marketscre... |
| 26.03.2018 | Beating out market leaders in PhII, antibiotic-maker ... | European biotech Allecra announced good news from the frontlines of its fight against multidr... | endpts.com... |
| 16.06.2016 | FCF II Co-Invest I supports EUR 22M Series B of Allecra Ther... | Forbion Capital Partners, the Dutch life sciences venture capital firm, today announced that it has ... | forbion.co... |
| 15.06.2016 | Biopharmaceutical Company Allecra Therapeutics Closes €22M S... | Allecra Therapeutics, a Lorrach, Germany and Saint Louis, France-based biopharmaceutical company ded... | finsmes.co... |
| 15.06.2016 | Delos Capital Leads $24.7M Series B for Allecra Therapeutics | Allecra Therapeutics, a biopharmaceutical company dedicated to the development of novel antibiotics ... | citybizlis... |
| 18.04.2013 | Antibiotics upstart Allecra snags €15M VC round amid superbu... | Amid an outcry for new options against drug-resistant bacteria, Allecra Therapeutics has taken off w... | fiercebiot... |
| 18.04.2013 | Allecra Therapeutics Inks EURO15M Series A | LORRACH, GERMANY and SAINT LOUIS, FRANCE, Biopharmaceutical company dedicated to the development o... | vcnewsdail... |
Show more